Teva Pharmaceuticals expects completion of $40.5 billion Allergan generics deal by June
The Israel-based drug maker, Teva Pharmaceuticals, is expecting to complete the process of Allergan's acquistion by June. This deal will further increase Teva's dominance in the drug industry.